Improving patient access to life-enhancing medications

Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercialising pharmaceuticals.

We have a 40-year track record of innovation and success developing new oral drug delivery systems and these technologies have been successfully commercialised in numerous products that continue to be marketed around the world.

More about us Our capabilities
A couple with adult children and a dog walk in nature, parents with two adult daughters

We offer patients better, safe & more accessible medicines.

View our products Explore our capabilities
Man looking in microscope

Capabilities

To improve patient access to life-enhancing prescription medications, Mayne Pharma offers a robust portfolio of branded and generic drugs in multiple therapeutic areas, including women's health and dermatology.

Learn more
Pills

Contract services

Mayne Pharma has a full service contract development and manufacturing organisations (CDMO) specialising in novel oral and topical dose forms providing pharmaceutical development, analytical testing and commercial manufacturing to clients worldwide. Our mission is to partner with clients to develop and deliver pharmaceutical products from “concept to commercialisation” to change the lives of patients around the globe:

Learn more

Sustainability

At Mayne Pharma, we recognise that we are part of a global community. As part of this community, we are committed to operating our business in a sustainable manner. We ensure our people are safe and well-supported, local communities prosper and the environment is well cared for so that it benefits future generations.

Learn more

For investors

Company Announcements